首页TWST • NASDAQ
add
Twist Bioscience Corp
昨日收盘价
$42.79
当日价格范围
$43.17 - $44.54
年度波幅
$14.43 - $60.90
市值
25.39亿 USD
平均交易量
74.56万
市盈率
-
股息率
-
主要交易所
NASDAQ
财务信息
损益表
收入
净收入
| (USD) | 2024年6月info | 年同比变化 |
|---|---|---|
收入 | 8146.40万 | 27.81% |
经营支出 | 7926.30万 | 12.29% |
净收入 | -8557.10万 | -49.09% |
净利润率 | -105.04 | -16.65% |
每股收益 | -0.70 | 31.23% |
息税折旧摊销前利润 | -3569.10万 | 11.22% |
有效税率 | -0.22% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年6月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.89亿 | -18.96% |
总资产 | 6.38亿 | -21.25% |
负债总额 | 1.47亿 | -3.80% |
权益总额 | 4.91亿 | — |
发行在外的股份 | 5858.60万 | — |
市净率 | 5.10 | — |
资产回报率 | -16.40% | — |
资本回报率 | -17.91% | — |
现金流
现金净变动
| (USD) | 2024年6月info | 年同比变化 |
|---|---|---|
净收入 | -8557.10万 | -49.09% |
来自运营的现金 | -637.80万 | 72.76% |
投资现金 | -71.10万 | -103.81% |
融资现金 | 290.80万 | 539.94% |
现金净变动 | -417.90万 | 26.98% |
自由现金流 | 602.20万 | 464.11% |
简介
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
CEO
成立时间
2013
员工数量
919
